• Something wrong with this record ?

Ionic Environment Affects Biomolecular Interactions of Amyloid-β: SPR Biosensor Study

E. Hemmerová, T. Špringer, Z. Krištofiková, J. Homola

. 2020 ; 21 (24) : . [pub] 20201220

Language English Country Switzerland

Document type Journal Article

Grant support
20-23787X Grantová Agentura České Republiky
19-02739S Grantová Agentura České Republiky

In early stages of Alzheimer's disease (AD), amyloid beta (Aβ) accumulates in the mitochondrial matrix and interacts with mitochondrial proteins, such as cyclophilin D (cypD) and 17β-hydroxysteroid dehydrogenase 10 (17β-HSD10). Multiple processes associated with AD such as increased production or oligomerization of Aβ affect these interactions and disbalance the equilibrium between the biomolecules, which contributes to mitochondrial dysfunction. Here, we investigate the effect of the ionic environment on the interactions of Aβ (Aβ1-40, Aβ1-42) with cypD and 17β-HSD10 using a surface plasmon resonance (SPR) biosensor. We show that changes in concentrations of K+ and Mg2+ significantly affect the interactions and may increase the binding efficiency between the biomolecules by up to 35% and 65% for the interactions with Aβ1-40 and Aβ1-42, respectively, in comparison with the physiological state. We also demonstrate that while the binding of Aβ1-40 to cypD and 17β-HSD10 takes place preferentially around the physiological concentrations of ions, decreased concentrations of K+ and increased concentrations of Mg2+ promote the interaction of both mitochondrial proteins with Aβ1-42. These results suggest that the ionic environment represents an important factor that should be considered in the investigation of biomolecular interactions taking place in the mitochondrial matrix under physiological as well as AD-associated conditions.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019628
003      
CZ-PrNML
005      
20220221095950.0
007      
ta
008      
210728s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21249727 $2 doi
035    __
$a (PubMed)33419257
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hemmerová, Erika, $u Institute of Photonics and Electronics of the Czech Academy of Sciences, Chaberská 1014/57, 182 51 Prague, Czech Republic $d 1991- $7 xx0269692
245    10
$a Ionic Environment Affects Biomolecular Interactions of Amyloid-β: SPR Biosensor Study / $c E. Hemmerová, T. Špringer, Z. Krištofiková, J. Homola
520    9_
$a In early stages of Alzheimer's disease (AD), amyloid beta (Aβ) accumulates in the mitochondrial matrix and interacts with mitochondrial proteins, such as cyclophilin D (cypD) and 17β-hydroxysteroid dehydrogenase 10 (17β-HSD10). Multiple processes associated with AD such as increased production or oligomerization of Aβ affect these interactions and disbalance the equilibrium between the biomolecules, which contributes to mitochondrial dysfunction. Here, we investigate the effect of the ionic environment on the interactions of Aβ (Aβ1-40, Aβ1-42) with cypD and 17β-HSD10 using a surface plasmon resonance (SPR) biosensor. We show that changes in concentrations of K+ and Mg2+ significantly affect the interactions and may increase the binding efficiency between the biomolecules by up to 35% and 65% for the interactions with Aβ1-40 and Aβ1-42, respectively, in comparison with the physiological state. We also demonstrate that while the binding of Aβ1-40 to cypD and 17β-HSD10 takes place preferentially around the physiological concentrations of ions, decreased concentrations of K+ and increased concentrations of Mg2+ promote the interaction of both mitochondrial proteins with Aβ1-42. These results suggest that the ionic environment represents an important factor that should be considered in the investigation of biomolecular interactions taking place in the mitochondrial matrix under physiological as well as AD-associated conditions.
650    _2
$a 17-hydroxysteroidní dehydrogenasy $x chemie $x genetika $7 D015067
650    _2
$a Alzheimerova nemoc $x diagnóza $x genetika $x patologie $7 D000544
650    _2
$a amyloidní beta-protein $x chemie $7 D016229
650    _2
$a biosenzitivní techniky $x metody $7 D015374
650    _2
$a peptidylprolylisomerasa F $x chemie $x genetika $7 D000081406
650    _2
$a lidé $7 D006801
650    _2
$a ionty $x chemie $7 D007477
650    _2
$a mitochondrie $x chemie $7 D008928
650    _2
$a mitochondriální proteiny $x chemie $7 D024101
650    _2
$a peptidové fragmenty $x chemie $x genetika $7 D010446
650    _2
$a povrchová plasmonová rezonance $x metody $7 D020349
655    _2
$a časopisecké články $7 D016428
700    1_
$a Špringer, Tomáš $u Institute of Photonics and Electronics of the Czech Academy of Sciences, Chaberská 1014/57, 182 51 Prague, Czech Republic
700    1_
$a Krištofiková, Zdeňka $u National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
700    1_
$a Homola, Jiří $u Institute of Photonics and Electronics of the Czech Academy of Sciences, Chaberská 1014/57, 182 51 Prague, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 24 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33419257 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20220221095948 $b ABA008
999    __
$a ok $b bmc $g 1690446 $s 1140074
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 24 $e 20201220 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 20-23787X $p Grantová Agentura České Republiky
GRA    __
$a 19-02739S $p Grantová Agentura České Republiky
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...